We are live on
!
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$88M
1-Year Est. Return
48.84%
This Fund
S&P 500
This Quarter
Est. Return
-4.28%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$27.9M
AUM Growth
+$12.7M
(+84%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
43.59%
Top 10 Holdings %
Top 10 Hldgs %
17.59%
Holding
150
New
90
Increased
7
Reduced
6
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INSY
Insys Therapeutics, Inc.
INSY
|
+$637K |
| 2 |
Live Nation Entertainment
LYV
|
+$625K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$462K |
| 4 |
Western Alliance Bancorporation
WAL
|
+$461K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$460K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$519K |
| 2 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$510K |
| 3 |
ESPR
Esperion Therapeutics
ESPR
|
+$443K |
| 4 |
Murphy USA
MUSA
|
+$440K |
| 5 |
DGI
DigitalGlobe Inc.
DGI
|
+$374K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Consumer Discretionary | 13.09% |
| 3 | Healthcare | 12.68% |
| 4 | Industrials | 11.61% |
| 5 | Financials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Live Nation Entertainment
LYV
$42.9B
| $639K | 2.29% |
+28,624
| New | +$625K |
|
|
CNH
2
CNH Industrial
CNH
$13.3B
| $545K | 1.95% |
92,714
+75,200
| +429% | +$424K |
|
|
INSY
3
DELISTED
Insys Therapeutics, Inc.
INSY
| $537K | 1.93% |
+33,562
| New | +$637K |
|
|
4
Western Alliance Bancorporation
WAL
$8.81B
| $492K | 1.76% |
+14,749
| New | +$461K |
|
5
MillerKnoll
MLKN
$1.56B
| $468K | 1.68% |
+15,151
| New | +$403K |
|
6
Saic
SAIC
$4.95B
| $468K | 1.68% |
+8,769
| New | +$390K |
|
|
QVCGA
7
DELISTED
QVC Group Inc Series A
QVCGA
| $456K | 1.63% |
+372
| New | +$453K |
|
8
Guidewire Software
GWRE
$13.9B
| $442K | 1.58% |
+8,114
| New | +$424K |
|
|
IMS
9
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $441K | 1.58% |
16,619
+8,624
| +108% | +$214K |
|
10
Telephone and Data Systems
TDS
$3.87B
| $419K | 1.5% |
13,940
-2,447
| -15% | -$61.7K |
|
11
MannKind Corp
MNKD
$1.19B
| $417K | 1.5% |
51,802
-7,369
| -12% | -$42.1K |
|
12
Usana Health Sciences
USNA
$419M
| $410K | 1.47% |
+6,756
| New | +$398K |
|
|
13
Regeneron Pharmaceuticals
REGN
$72.9B
| $404K | 1.45% |
+1,120
| New | +$462K |
|
|
14
Vertex Pharmaceuticals
VRTX
$123B
| $404K | 1.45% |
+5,083
| New | +$460K |
|
15
Loews
L
$24.5B
| $402K | 1.44% |
+10,505
| New | +$387K |
|
16
Johnson Controls International
JCI
$85.1B
| $401K | 1.44% |
+9,836
| New | +$376K |
|
17
Howard Hughes
HHH
$3.94B
| $380K | 1.36% |
3,762
-413
| -10% | -$37.9K |
|
|
DISH
18
DELISTED
DISH Network Corp.
DISH
| $375K | 1.34% |
+8,114
| New | +$391K |
|
19
Adeia
ADEA
$2.55B
| $372K | 1.33% |
+45,420
| New | +$346K |
|
20
Southern Copper
SCCO
$138B
| $364K | 1.31% |
+14,179
| New | +$335K |
|
21
LKQ Corp
LKQ
$6.72B
| $357K | 1.28% |
+11,173
| New | +$312K |
|
|
AFSI
22
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $353K | 1.27% |
+13,625
| New | +$362K |
|
|
HBI
23
DELISTED
Hanesbrands
HBI
| $349K | 1.25% |
+12,328
| New | +$353K |
|
24
Spectrum Brands
SPB
$2.03B
| $342K | 1.23% |
+3,130
| New | +$309K |
|
|
CLC
25
DELISTED
Clarcor
CLC
| $341K | 1.22% |
+5,893
| New | +$291K |
|
Similar funds
BCP
PBCM
CVM
XXIP
DG
RFL
IAP
MPEM
Parametrica Management's Q1 2016 Portfolio in Review
As of Q1 2016, Parametrica Management held 150 positions worth $27.9M, up 84% from $15.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Parametrica Management deployed $12.2M of net new capital in Q1 2016, opening 90 new positions and adding to 7 existing holdings. Its largest new stake was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Finisar Corp, an estimated $315K trimmed.
- Parametrica Management's largest Q1 2016 buy was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
- Parametrica Management added most to CNH Industrial in Q1 2016, an estimated $424K increase.
- Parametrica Management's biggest Q1 2016 reduction was Finisar Corp, cutting an estimated $315K.
- Parametrica Management fully exited PTC Therapeutics in Q1 2016, selling an estimated $519K.
- Parametrica Management's ten largest holdings make up 18% of its $27.9M portfolio in Q1 2016.
- Parametrica Management opened 90 new positions and closed 47 in Q1 2016.
- Parametrica Management's portfolio value rose 84% quarter-over-quarter to $27.9M.
Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.